Saturday, 20 April 2024
Tianjin Zhong Xin Pharm Group
-
Overlay
-
Indicators
-
Settings
-
Period
18:45 | 15/8/11
CapitalVue
August 15 -- Tianjin Lisheng Pharmaceutical (002393), a maker of cardiovascular and antihypertensive medicines, plans to purchase 49 percent and 51 percent stakes in Tianjin Central Pharma from ...
more»
21:26 | 29/4/11
Reuters Key Development
Tianjin Zhong Xin Pharmaceutical Group Does Not Recommend Dividend
more»
23:28 | 30/3/11
Business Times
By MINDY TAN Tianjin Zhong Xin Pharmaceutical Group posted a net profit of RMB293.29 million (US$44.62 million) for the financial year ended 31 December 2010, up 9 per cent from 2009. Revenue for ...
more»
22:19 | 30/3/11
Reuters Key Development
Tianjin Zhong Xin Pharmaceutical Group Announces Final Dividend
more»